Table 1.
Demographic and Clinical Features of Patients in Treatment Groups
| Group 1 ILT: 5 mg/mL (N=46) | Group 2 ILT: 10 mg/mL (N=39) | P-value | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Gender | |||||
| Female | 21 | 45.7 | 17 | 56.4 | 0.323 |
| Male | 25 | 54.3 | 22 | 43.6 | |
| Age | |||||
| Mean (SD) (years) | 20.9 (11) | 27.8 (14) | |||
| ≤18 | 17 | 37.0 | 11 | 28.2 | 0.333 |
| 19–30 | 21 | 45.7 | 16 | 41.0 | |
| >30 | 8 | 17.4 | 12 | 30.8 | |
| Duration of treated AA patches | |||||
| Mean (SD) (months) | 13.6 (27) | 10.5 (17) | 0.933 | ||
| ≤2 | 16 | 34.8 | 15 | 38.5 | |
| 3–6 | 13 | 28.3 | 10 | 25.6 | |
| >6 | 17 | 37.0 | 14 | 35.9 | |
| Number of patches | |||||
| Mean (SD) | 3.4 (4.2) | 3.1 (3.7) | 0.652 | ||
| 1 | 16 | 34.8 | 17 | 43.6 | |
| 2 | 14 | 30.4 | 9 | 23.1 | |
| ≥3 | 16 | 34.8 | 13 | 33.3 | |
| Scalp surface area affected % | |||||
| Mean (SD) | 5.4 (5.2) | 5.3 (5.4) | 0.858 | ||
| <3 | 14 | 30.4 | 14 | 35.9 | |
| 3–5 | 16 | 34.8 | 12 | 30.8 | |
| 6+ | 16 | 34.8 | 13 | 33.3 | |
| Past history of AA | 11 | 23.9 | 11 | 28.2 | 0.653 |
| Personal history of atopy (atopic dermatitis, asthma, allergic rhinitis) | 13 | 28.3 | 9 | 23.1 | 0.587 |
| Comorbidities (hypothyroidism, low ferritin, hypertension, diabetes mellitus, juvenile rheumatoid arthritis, vitiligo, psoriasis, depression, anxiety) | 13 | 28.3 | 9 | 23.1 | 0.587 |
| Nail involvement (fine pitting, trachyonychia, leuconychia) | 4 | 8.7 | 2 | 5.1 | 0.522 |
| Extra scalp sites (eyebrow, moustache, legs, beard) | 10 | 21.7 | 7 | 17.9 | 0.663 |
| Family history of AA | 6 | 13 | 7 | 17.9 | 0.536 |